Why is diversity in clinical trials important? 

Learn about CHI's efforts to make clinical trials and healthcare more diverse.


 What is the relationship between the value and cost of a drug as related to treatment of a disease? 

Learn about our research exploring the relationship between drug costs and value


 What does patient-driven healthcare value mean? 

Learn more about our healthcare executive roundtable


Increasing Knowledge Understanding

of Healthcare Value.

learn more

The Center for Healthcare Innovation is an independent, non-profit 501(c)(3) research and educational institute that helps patients and providers increase their knowledge and understanding of the opportunities and challenges of maximizing healthcare value to improve health and quality of life. We aim to make the world a healthier place.







Latest CHI Insights / View All Posts


What Changing U.S. Demographics Mean for Clinical Trials

The Food and Drug Administration has declared a renewed focus for 2016 exploring diversity in clinical trials. [1] Data gathered from FDA shows that there is still a significant lack of patient diversity in clinical trials.  “While African-Americans/Blacks represent 12% of the total U.S. population, they comprise just 5% of ...
Read More

Improving Access for LGBT Clinical Trial Initiatives

In early April of 2016, Washington State lawmakers passed a bill to improve health research for individuals of the Lesbian, Gay, Bisexual, and Transgender community. Since the state of Washington has a significant LGBT population (more than 173,000 LGBT individuals in Seattle alone), Washington State lawmakers felt it was time ...
Read More

The Evolving Role of Healthcare Providers

The Evolving Role of Healthcare Providers We are in an age of healthcare consumerism where patients' interests are more vested than ever. It's important for providers to accommodate the power shift. This means increasing transparency, finding new ways to facilitate communication, responding directly to patient concerns and questions when raised, and ...
Read More

The Urgency in Increasing Diversity in Clinical Trials

  The Food and Drug Administration (FDA), the key regulatory authority in bringing new drugs to the market, must balance between introducing life-saving treatments to people who need them as soon as possible and ensuring that these drugs have been thoroughly tested and are safe for the general population. A drug ...
Read More


Patient Educational Workshop

“CHI’s Patient-Focused Roundtable featured an outstanding cross-sectional representation of healthcare experts which provided the basis for a stimulating discussion on the meaning of patient-centricity and value from diverse perspectives” – Dr. Greg Gilmet, MD, MPH, Vice President Medical and Scientific Affairs, Upsher-Smith Laboratories


 2015 Impact Report 

Learn about how we encourage and enable meaningful and executable innovation that aims to address existing and ensuing healthcare dynamics through communication, education, training, symposia, reports, and research.